跳至主要内容
临床试验/CTRI/2022/01/039339
CTRI/2022/01/039339尚未招募不适用

Comparing safety of two drug regimens for pupillary dilatation for retinopathy of prematurity screening in preterm neonates: A double blinded Randomized Controlled Trial

AIIMS New Delhi1 个研究点 分布在 1 个国家目标入组 230 人开始时间: 2022年12月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
230
试验地点
1
主要终点
a 3-step combination of

研究概览

简要总结

·        Retinopathy of prematurity (ROP) is a common complication related to preterm neonates. Various dilatation protocols are being used for mydriasis during ROP screening. We aim to compare the safety of two mydriatic regimens using 0.5% Tropicamide two times followed by 2.5% Phenylephrine+ 0.5% Tropicamide (intervention group) Vs combination of 2.5% Phenylephrine+ 0.5% Tropicamide used thrice (control group). We hypothesize that using the 3-step combination of 0.5% tropicamide plus 0.5% tropicamide plus 0.5% tropicamide+2.5% phenylephrine eye drops for pupillary dilatation in preterm neonates undergoing ROP screening will result in 50% less increase in the diastolic blood pressure and heart rate at 15+5 minutes after screening, when compared to use of 0.5 % tropicamide+ 2.5% phenylephrine combination eye drops used thrice.

研究设计

研究类型
Interventional
分配方式
Stratified block randomization
盲法
Participant and Investigator Blinded

入排标准

年龄范围
1.00 Month(s) 至 5.00 Month(s)(—)
性别
All

入选标准

  • Gestational age at birth is less than 34 weeks or birth weight <1500 gm.

排除标准

  • Major malformation
  • Hemodynamic instability
  • Suspicion of cardiovascular disease
  • Anatomical variations of the anterior segment
  • Consent denied by the parents/ attendants.

结局指标

主要结局

a 3-step combination of

时间窗: 15 minutes after the retinopathy of prematurity screening procedure

0.5% tropicamide plus 0.5% tropicamide followed by 2.5% phenylephrine+0.5%

时间窗: 15 minutes after the retinopathy of prematurity screening procedure

thrice will cause 50% less increase in diastolic

时间窗: 15 minutes after the retinopathy of prematurity screening procedure

blood pressure

时间窗: 15 minutes after the retinopathy of prematurity screening procedure

tropicamide vs. a combination of 2.5% phenylephrine+0.5% tropicamide used

时间窗: 15 minutes after the retinopathy of prematurity screening procedure

次要结局

  • To compare the mydriatic efficacy and suitability of pupillary dilatation by assessing the need for rescue dose of the two mydriatic regimens being compared.(Before ROP screening (after instillation of mydriatic drops) to 24 hrs after)

研究者

发起方
AIIMS New Delhi
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验